Evidence map›Paper›PMID 23265693›Full record

ReviewThe Journal of allergy and clinical immunology2013

Can we produce true tolerance in patients with food allergy?

M Cecilia Berin, Lloyd Mayer

Abstract readReview
In one paragraph

Review in The Journal of allergy and clinical immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 82 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Combined Effects ofAllergy, asthma & immunology research · 2020
    Article
  8. New Perspectives in Food Allergy.International journal of molecular sciences · 2020
    Review
  9. Evolution of Immune Responses in Food Immunotherapy.Immunology and allergy clinics of North America · 2020
    Review
  10. Review
  11. Immunotherapy of Food Allergy: a Comprehensive Review.Clinical reviews in allergy & immunology · 2019
    Review
  12. Oral immunotherapy with omalizumab reverses the Th2 cell-like programme of regulatory T cells and restores their function.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2018
    Article
  13. Oral Tolerance Development and Maintenance.Immunology and allergy clinics of North America · 2018
    Review
  14. Article
  15. Article
  16. Deciphering the black box of food allergy mechanisms.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2017
    Review
  17. Epicutaneous immunotherapy induces gastrointestinal LAPThe Journal of allergy and clinical immunology · 2017
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M Cecilia BerinJaffe Food Allergy Institute, Mount Sinai School of Medicine, New York, NY 10029, USA. cecilia.berin@mssm.edu
Lloyd Mayer
Icahn School of Medicine at Mount Sinai · US

Funding

THE ROLE OF ICSBP IN MUCOSAL IMMUNE RESPONSEP01DK072201 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HARPAZ, NOAM · 2006 to 2015
$14.6M
Tolerance vs. Allergenicity; Factors Dictating Differing ResponsesU19AI044236 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SAMPSON, HUGH A · 2008 to 2014
$9.8M
ORAL TOLERANCE AND COW MILK ALLERGYP01AI044236 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SAMPSON, HUGH · 1999 to 2007
$7.5M
Role of T cells in gastrointestinal manifestations of food allergyR01AI093577 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BERIN, CECILIA · 2012 to 2016
$2.1M
NIAID NIH HHS AI044236NIAID NIH HHS P01 AI044236NIAID NIH HHS R01 AI093577NIAID NIH HHS U19 AI044236NIDDK NIH HHS P01 DK072201
6 · The paper itself

Abstract

Immune tolerance is defined as nonresponsiveness of the adaptive immune system to antigens. Immune mechanisms preventing inappropriate immune reactivity to innocuous antigens include deletion of reactive lymphocytes and generation of regulatory T (Treg) cells. The normal response to food antigens is the generation of antigen-specific Treg cells. In patients with food allergy, the dominant immune response is a T(H)2-skewed T-cell response and the generation of food-specific IgE antibodies from B cells. It is not known whether a failure of the Treg cell response is behind this inappropriate immune response, but interventions that boost the Treg cell response, such as mucosal immunotherapy, might lead to a restoration of immune tolerance to foods. Tolerance has been notoriously difficult to restore in animal disease models, but limited data from human trials suggest that tolerance (sustained nonresponsiveness) can be re-established in a subset of patients. Furthermore, studies on the natural history of food allergy indicate that spontaneous development of tolerance to foods over time is not uncommon. The current challenge is to understand the mechanisms responsible for restoration of natural or induced tolerance so that interventions can be developed to more successfully induce tolerance in the majority of patients with food allergy.

Indexed as

Immune ToleranceFood HypersensitivityGastric MucosaHumansImmunity, MucosalImmunotherapyIntestinal MucosaT-Lymphocytes, Regulatory

Identifiers

PMID23265693
PMCPMC3807570
OpenAlexW1974427279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.